The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Keflex 500 mg Film-Coated Tablets



Flynn Pharma LimitedPA1226/002/004

Main Information

Trade NameKeflex 500 mg Film-Coated Tablets
Active SubstancesCefalexin Anhydrous
Dosage FormFilm-coated tablet
Licence HolderFlynn Pharma Limited
Licence NumberPA1226/002/004

Group Information

ATC CodeJ01DB First-generation cephalosporins
J01DB01 cefalexin

Status

License statusAuthorised
Licence Issued14/04/1977
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back